Role of Narrow Band Imaging in Management of Urothelial Carcinoma

Current Urology Reports

Volumn 16, Issue 8, 2015, Pages

  Altobelli, Emanuela ^a,b   Zlatev, Dimitar V ^a   Liao, Joseph C ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Diagnostic ureteroscopy; Narrow band imaging; Transurethral resection; Urothelial carcinoma; White light cystoscopy

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; BCG VACCINE;

CANCER DIAGNOSIS; CARCINOMA IN SITU; CONFOCAL LASER MICROSCOPY; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IMAGING; HUMAN; NARROW BAND IMAGING; PHOTODYNAMIC DIAGNOSIS; REVIEW; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR RECURRENCE; URETEROSCOPE; URETEROSCOPY; MYCOBACTERIUM BOVIS; PATHOLOGY; PROCEDURES; RECURRENT DISEASE; URINARY BLADDER NEOPLASMS;

CYSTOSCOPY; HUMANS; MYCOBACTERIUM BOVIS; NARROW BAND IMAGING; RECURRENCE; URINARY BLADDER NEOPLASMS;

EID: 84934957415     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-015-0527-5     Document Type: Review

References (51)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.
2. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41. doi:10.1016/j.eururo.2012.07.033.
3. Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract. Actas Urol Esp. 2012;36(1):2–14. doi:10.1016/j.acuro.2011.09.001.
4. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6 Suppl 1):4–34. doi:10.1016/j.urology.2005.07.062.
5. Morgan TM, Keegan KA, Clark PE. Bladder cancer. Curr Opin Oncol. 2011;23(3):275–82. doi:10.1097/CCO.0b013e3283446a11.
6. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466–5. doi:10.1016/j.eururo.2005.12.031. discussion 75–7.
7. Olgac S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28(12):1545–52.
8. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178(1):68–73. doi:10.1016/j.juro.2007.03.028. discussion.
9. Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174(3):862–6. doi:10.1097/01.ju.0000169257.19841.2a. discussion 6.
10. Cina SJ, Epstein JI, Endrizzi JM, Harmon WJ, Seay TM, Schoenberg MP. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol. 2001;32(6):630–7. doi:10.1053/hupa.2001.24999.
11. Babjuk M, Soukup V, Petrik R, Jirsa M, Dvoracek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96(6):798–802. doi:10.1111/j.1464-410X.2004.05715.x.
12. Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174(6):2129–33. doi:10.1097/01.ju.0000181814.73466.14. discussion 33.
13. Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol. 2000;113(2):275–9. doi:10.1309/94b6-8vfb-mn9j-1nf5.
14. Liu JJ, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: considerations and perspectives. J Urol. 2012;188(2):361–8. doi:10.1016/j.juro.2012.03.127.
15. Herr H, Donat M, Dalbagni G, Taylor J. Narrow-band imaging cystoscopy to evaluate bladder tumours–individual surgeon variability. BJU Int. 2010;106(1):53–5. doi:10.1111/j.1464-410X.2009.09119.x.
16. Bryan RT, Shah ZH, Collins SI, Wallace DM. Narrow-band imaging flexible cystoscopy: a new user’s experience. J Endourol / Endourol Soc. 2010;24(8):1339–43. doi:10.1089/end.2009.0598.
17. Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int. 2008;101(6):702–5. doi:10.1111/j.1464-410X.2007.07317.x. discussion 5–6.
18. Cauberg EC, Kloen S, Visser M, de la Rosette JJ, Babjuk M, Soukup V, et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology. 2010;76(3):658–63. doi:10.1016/j.urology.2009.11.075.
19. Chen G, Wang B, Li H, Ma X, Shi T, Zhang X. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder. Urol Oncol. 2013;31(4):475–9. doi:10.1016/j.urolonc.2011.02.009.
20. Geavlete B, Jecu M, Multescu R, Geavlete P. Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach. Ther Adv Urol. 2012;4(5):211–7. doi:10.1177/1756287212454181.
21. Shen YJ, Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, et al. Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a “second look” matters? Int Urol Nephrol. 2012;44(2):451–7. doi:10.1007/s11255-011-0036-5.
22. Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S, et al. Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol / Endourol Soc. 2010;24(11):1807–11. doi:10.1089/end.2010.0055.
23. Li K, Lin T, Fan X, Duan Y, Huang J. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol. 2013;20(6):602–9. doi:10.1111/j.1442-2042.2012.03211.x.
24. Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q. Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int. 2012;110(11 Pt B):E680-7. doi:10.1111/j.1464-410X.2012.11500.x.
25. Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int. 2008;102(9):1111–4. doi:10.1111/j.1464-410X.2008.07846.x.
26. Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors—results of a prospective, randomized comparison to the standard approach. Urology. 2012;79(4):846–51. doi:10.1016/j.urology.2011.08.081.
27. Herr HW, Donat SM. Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU Int. 2011;107(3):396–8. doi:10.1111/j.1464-410X.2010.09547.x.
28. Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol. 2012;61(5):908–13. doi:10.1016/j.eururo.2012.01.018. This randomized prospective trial assessed the impact of NBI on 1-year bladder cancer recurrence risk and found that TUR performed under NBI significantly reduced recurrence risk in comparison to WLC.
29. Herr HW. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors. Eur Urol. 2014. doi:10.1016/j.eururo.2014.06.049. This randomized controlled trial showed that NBI-assisted TUR of bladder tumors significantly reduced the recurrence rate and improved recurrence-free survival when compared to WLC-assisted TUR.
30. de la Rosette J, Gravas S. A multi-center, randomized international study to compare the impact of narrow band imaging versus white light cystoscopy in the recurrence of bladder cancer. J Endourol / Endourol Soc. 2010;24(5):660–1. doi:10.1089/end.2010.1510.
31. Naito S, van Rees Vellinga S, de la Rosette J. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. J Endourol / Endourol Soc. 2013;27(1):1–3. doi:10.1089/end.2012.1556. This is an update on the international multicenter randomized controlled trial launched in 2010 with the aim to compare the recurrence rate at 1 year after NBI- and WLC-assisted TUR in patients with non-muscle-invasive bladder cancer. The study includes 24 centers and is nearing completion of goal enrollment of 1000 patients.
32. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–53. doi:10.1016/j.eururo.2013.06.003.
33. Herr HW. Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guerin therapy: preliminary results. BJU Int. 2010;105(3):314–6. doi:10.1111/j.1464-410X.2009.08788.x.
34. Traxer O, Geavlete B, de Medina SG, Sibony M, Al-Qahtani SM. Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience. J Endourol / Endourol Soc. 2011;25(1):19–23. doi:10.1089/end.2009.0593.
35. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63(6):1059–71. doi:10.1016/j.eururo.2013.03.032.
36. Cornu JN, Roupret M, Carpentier X, Geavlete B, de Medina SG, Cussenot O, et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol. 2010;28(2):151–6. doi:10.1007/s00345-009-0494-x.
37. Lucas SM, Svatek RS, Olgin G, Arriaga Y, Kabbani W, Sagalowsky AI, et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int. 2008;102(2):172–6. doi:10.1111/j.1464-410X.2008.07535.x.
38. Roupret M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol. 2007;51(3):709–13. doi:10.1016/j.eururo.2006.07.019. discussion 14.
39. Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, et al. A comparison of hexaminolevulinate (Hexvix((R))) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc. 2012;26(12):3634–41. doi:10.1007/s00464-012-2387-0.
40. Rink M, Babjuk M, Catto JW, Jichlinski P, Shariat SF, Stenzl A, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol. 2013;64(4):624–38. doi:10.1016/j.eururo.2013.07.007.
41. Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57(4):595–606. doi:10.1016/j.eururo.2009.11.041.
42. Somani BK, Moseley H, Eljamel MS, Nabi G, Kata SG. Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique. Photodiagnosis Photodyn Ther. 2010;7(1):39–43. doi:10.1016/j.pdpdt.2009.12.005.
43. Chang TC, Liu JJ, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;(71):e4409. doi:10.3791/4409.
44. Sonn GA, Jones SN, Tarin TV, Du CB, Mach KE, Jensen KC, et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182(4):1299–305. doi:10.1016/j.juro.2009.06.039.
45. Chang TC, Liu JJ, Hsiao ST, Pan Y, Mach KE, Leppert JT, et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol / Endourol Soc. 2013;27(5):598–603. doi:10.1089/end.2012.0549.
46. Goh AC, Tresser NJ, Shen SS, Lerner SP. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology. 2008;72(1):133–7. doi:10.1016/j.urology.2008.02.002.
47. Hermes B, Spoler F, Naami A, Bornemann J, Forst M, Grosse J, et al. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology. 2008;72(3):677–81. doi:10.1016/j.urology.2008.02.062.
48. Karl A, Stepp H, Willmann E, Buchner A, Hocaoglu Y, Stief C, et al. Optical coherence tomography for bladder cancer—ready as a surrogate for optical biopsy? Results of a prospective mono-centre study. Eur J Med Res. 2010;15(3):131–4.
49. Bus MT, Muller BG, de Bruin DM, Faber DJ, Kamphuis GM, van Leeuwen TG, et al. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study. J Urol. 2013;190(6):2236–42. doi:10.1016/j.juro.2013.08.006.
50. Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound Med Offic J Am Instit Ultrasound Med. 2010;29(9):1277–84.
51. Gravas S, Stenzl A. The Storz professional image enhancement system (SPIES) nonmuscle-invasive bladder cancer study: a multicenter international randomized controlled study. J Endourol / Endourol Soc. 2014;28(11):1254–5. doi:10.1089/end.2014.1651.